EUVIMEDEUVIMED entdecken
Crossref

Dual-Enhanced Lateral Flow Immunoassay: Synergizing Oriented Antibody Anchoring and Nanozyme Catalytic Amplification for Ultrasensitive Cancer Detection

Qing Yang, Wanchao Zuo, Jiaren Song, Siqi Zeng, Xiangming Meng, Zhipeng Ding, Qiannan Hu, Xuhui Tan, Donghui Zhang iD, Jianjun Dai, Yanmin Ju iD

Analytical Chemistry · 12.08.2025 · 97 (31) · 16942-16949

DOI: 10.1021/acs.analchem.5c02403 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytical Chemistry, online erschienen am 31.07.2025. Verfasst von Qing Yang und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines, School of Pharmacy, China Pharmaceutical University, Nanjing 211198, China. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Neoplasms. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: National Key Research and Development Program of China, State Key Laboratory of Natural Medicines, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Conventional lateral flow immunoassays (LFIAs) suffer from limited sensitivity in detecting low-abundance tumor biomarkers, primarily attributed to inefficient antibody utilization and insufficient signal intensity of nano-immunoprobes. Here, we propose a dual-enhanced LFIA integrating oriented antibody anchoring and nanozyme catalytic amplification for ultrasensitive visual detection of tumor biomarkers, denoted as DEOAN-LFIA. Bimetallic catalyst gold-platinum nanoparticles (Au@Pt NPs) were functionalized with phenylboronic acid to selectively orient antibodies via fragment crystallizable (Fc) glycans for improving antibody utilization efficiency, thereby enriching target-probe complexes on the test line (T line), realizing the first-step signal amplification. Subsequently, the elevated local concentration of Au@Pt NPs efficiently catalyzed the conversion of chromogenic substrates into colored products, further amplifying the signal from enriched probes on the T line for the second-step signal amplification. Using common tumor markers alpha-fetoprotein (AFP) and carcinoembryonic antigen (CEA) as model targets, DEOAN-LFIA achieved ultrasensitive detection of picogram-level targets (50 pg/mL for AFP and 10 pg/mL for CEA) with rapid analysis within 25 min. Clinical validation with 36 human serum samples demonstrated favorable concordance with the standard clinical assay. This DEOAN-LFIA platform provides a robust ultrasensitive point-of-care tool for the early diagnosis of malignant diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomarkers, TumorNeoplasmsHumansImmunoassayGoldMetal NanoparticlesPlatinumalpha-FetoproteinsCatalysisLimit of DetectionCarcinoembryonic AntigenAntibodies, Immobilized

Substanzen

GoldBiomarkers, TumorPlatinumalpha-FetoproteinsCarcinoembryonic AntigenAntibodies, Immobilized

Autor:innen und Institutionen

  • State Key Laboratory of Natural Medicines, School of Pharmacy, China Pharmaceutical University, Nanjing 211198, China.
  • Zhanjiang Institute of Clinical Medicine, Guangdong Medical University Zhanjiang Central Hospital, Zhanjiang 524045, China.
  • MOE Joint International Research Laboratory of Animal Health and Food Safety, Key Laboratory of Animal Bacteriology, Ministry of Agriculture, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 2100…

ORCID-Profile: Donghui Zhang, Yanmin Ju

Förderung

  • National Key Research and Development Program of China
  • State Key Laboratory of Natural Medicines
  • Fundamental Research Funds for the Central Universities
  • Jiangsu Provincial Science and Technology Resources (Clinical Resources) Coordination Service Platform

Zitieren

APA

Yang, Q., Zuo, W., Song, J., Zeng, S., Meng, X., Ding, Z., Hu, Q., Tan, X., Zhang, D., Dai, J., & Ju, Y. (2025). Dual-Enhanced Lateral Flow Immunoassay: Synergizing Oriented Antibody Anchoring and Nanozyme Catalytic Amplification for Ultrasensitive Cancer Detection. Analytical Chemistry, 97(31), 16942-16949. https://doi.org/10.1021/acs.analchem.5c02403

Vancouver

Yang Q, Zuo W, Song J, Zeng S, Meng X, Ding Z, et al. Dual-Enhanced Lateral Flow Immunoassay: Synergizing Oriented Antibody Anchoring and Nanozyme Catalytic Amplification for Ultrasensitive Cancer Detection. Analytical Chemistry. 2025;97(31):16942-16949. doi:10.1021/acs.analchem.5c02403

BibTeX
@article{Yang2025,
  author = {Yang, Qing and Zuo, Wanchao and Song, Jiaren and Zeng, Siqi and Meng, Xiangming and Ding, Zhipeng and Hu, Qiannan and Tan, Xuhui and Zhang, Donghui and Dai, Jianjun and Ju, Yanmin},
  title = {Dual-Enhanced Lateral Flow Immunoassay: Synergizing Oriented Antibody Anchoring and Nanozyme Catalytic Amplification for Ultrasensitive Cancer Detection},
  journal = {Analytical Chemistry},
  year = {2025},
  volume = {97},
  number = {31},
  pages = {16942--16949},
  doi = {10.1021/acs.analchem.5c02403}
}
Kostenlos starten →